Iselin Dahlen Syversen

Sep 17, 2024 | onlinelibrary.wiley.com | Kevin A. Schulman |Aaron S. Kesselheim |William B. Feldman |Iselin Dahlen Syversen

Policy Points Health care systems around the world rely on a range of methods to ensure the affordability of prescription drugs, including negotiating prices soon after drug approval and relying on formal clinical assessments that compare newly approved therapies with existing alternatives. The negotiation framework established under the Inflation Reduction Act is far more limited than other frameworks explored in this study.